2024-03-28T19:30:38Zhttp://repisalud.isciii.es/oai/requestoai:repisalud.isciii.es:20.500.12105/131772023-10-13T09:22:36Zcom_20.500.12105_2152com_20.500.12105_2051com_20.500.12105_2144com_20.500.12105_2145col_20.500.12105_2153col_20.500.12105_2146
Repisalud
author
de Yebenes, Virginia G
author
Briones, Ana M
author
Martos-Folgado, Inmaculada
author
Mur, Sonia M.
author
Oller, Jorge
author
Bilal, Faiz
author
González-Amor, María
author
Mendez-Barbero, Nerea
author
Silla-Castro, Juan Carlos
author
Were, Felipe
author
Jimenez-Borreguero, Luis J
author
Sanchez-Cabo, Fatima
author
Bueno, Hector
author
Salaices, Mercedes
author
Redondo, Juan Miguel
author
Ramiro, Almudena R
funder
Asociación Española Contra el Cáncer
funder
Complutense University of Madrid (España)
funder
Fundación ProCNIC
funder
Ministerio de Ciencia e Innovación (España)
funder
Ministerio de Economía, Industria y Competitividad (España)
funder
Unión Europea. Comisión Europea. European Research Council (ERC)
funder
Instituto de Salud Carlos III
funder
Comunidad de Madrid (España)
funder
Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
2021-06-23T07:41:28Z
2021-06-23T07:41:28Z
2020-10
Arterioscler Thromb Vasc Biol. 2020; 40(10):2408-2424
1524-4636
http://hdl.handle.net/20.500.12105/13177
32847388
10.1161/ATVBAHA.120.314333
Arteriosclerosis, thrombosis, and vascular biology
microRNAs are master regulators of gene expression with essential roles in virtually all biological processes. miR-217 has been associated with aging and cellular senescence, but its role in vascular disease is not understood. Approach and Results: We have used an inducible endothelium-specific knock-in mouse model to address the role of miR-217 in vascular function and atherosclerosis. miR-217 reduced NO production and promoted endothelial dysfunction, increased blood pressure, and exacerbated atherosclerosis in proatherogenic apoE-/- mice. Moreover, increased endothelial miR-217 expression led to the development of coronary artery disease and altered left ventricular heart function, inducing diastolic and systolic dysfunction. Conversely, inhibition of endogenous vascular miR-217 in apoE-/- mice improved vascular contractility and diminished atherosclerosis. Transcriptome analysis revealed that miR-217 regulates an endothelial signaling hub and downregulates a network of eNOS (endothelial NO synthase) activators, including VEGF (vascular endothelial growth factor) and apelin receptor pathways, resulting in diminished eNOS expression. Further analysis revealed that human plasma miR-217 is a biomarker of vascular aging and cardiovascular risk.
Our results highlight the therapeutic potential of miR-217 inhibitors in aging-related cardiovascular disease.
eng
Aging-Associated miR-217 Aggravates Atherosclerosis and Promotes Cardiovascular Dysfunction.
journal article
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
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13177/1/AgingAssociatedmiR-217_2020.pdf
File
MD5
6c7cd94b582acacddec372c7fea003ee
5419663
application/pdf
AgingAssociatedmiR-217_2020.pdf
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13177/2/AgingAssociatedmiR-217_2020_supp1.pdf
File
MD5
32e352db8bc1c71ea18358064c1cddcf
1259875
application/pdf
AgingAssociatedmiR-217_2020_supp1.pdf
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13177/3/AgingAssociatedmiR-217_2020_supp2.pdf
File
MD5
52eae3133cf7dbcea3c4fdc4825e09c1
781034
application/pdf
AgingAssociatedmiR-217_2020_supp2.pdf
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13177/4/AgingAssociatedmiR-217_2020_supp3.avi
File
MD5
42b1da67a5c3966388751a25c5d668c7
1507474
application/octet-stream
AgingAssociatedmiR-217_2020_supp3.avi
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13177/7/AgingAssociatedmiR-217_2020.pdf.txt
File
MD5
a8c4dea95267ed931ede29912e095a69
80195
text/plain
AgingAssociatedmiR-217_2020.pdf.txt
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13177/9/AgingAssociatedmiR-217_2020_supp1.pdf.txt
File
MD5
520e9af9569bf7b77f4d7f61183cde35
8710
text/plain
AgingAssociatedmiR-217_2020_supp1.pdf.txt
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13177/11/AgingAssociatedmiR-217_2020_supp2.pdf.txt
File
MD5
9e102593aa5c66968ed6663c0b936541
232685
text/plain
AgingAssociatedmiR-217_2020_supp2.pdf.txt